{"id":514320,"date":"2026-07-07T15:37:21","date_gmt":"2026-07-07T15:37:21","guid":{"rendered":"https:\/\/www.newsbeep.com\/nz\/514320\/"},"modified":"2026-07-07T15:37:21","modified_gmt":"2026-07-07T15:37:21","slug":"the-risks-and-benefits-of-synthetic-cells-qa-with-peter-carr","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/nz\/514320\/","title":{"rendered":"The Risks and Benefits of Synthetic Cells: Q&#038;A with Peter Carr"},"content":{"rendered":"<p>                <img decoding=\"async\" src=\"https:\/\/www.newsbeep.com\/nz\/wp-content\/uploads\/2026\/07\/webimage-Peter-Carr-highres-portrait-1.jpeg\" alt=\"Peter Carr, co-chair of the Committee on External Review of Environmental, Biosafety, and Biosecurity Considerations for Synthetic Cell Research and Development\" class=\"w-full h-full object-cover \"\/><\/p>\n<p>                            Peter Carr, co-chair of the Committee on External Review of Environmental, Biosafety, and Biosecurity Considerations for Synthetic Cell Research and Development<\/p>\n<p>A team at the University of Minnesota announced recently that it <a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/www.nytimes.com\/interactive\/2026\/07\/01\/science\/spudcells-synthetic-cell.html\">synthesized simple cells<\/a> that feed, grow, and reproduce \u2014 the latest advance in the rapidly growing field of synthetic cells, which was the topic of a recent report from the National Academies, <a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/www.nationalacademies.org\/projects\/DELS-BLS-22-12\/publication\/29325\">Supporting Responsible Innovation of Synthetic Cells: Biosafety, Biosecurity, and Environmental Considerations<\/a>.<\/p>\n<p>The 15-person report committee \u2014 which included experts in synthetic biology, biosecurity, bioethics, and other disciplines \u2014 was co-chaired by Peter Carr, a synthetic biologist and senior principal engineer at RTX BBN Technologies. Carr chatted with writer Sara Frueh about what synthetic cells are, their potential benefits and hazards, and how governance of this research should work.<\/p>\n<p>Q: Let\u2019s start with the basics: What are synthetic cells? And are they living or not?<\/p>\n<p>Carr: Those questions are simple and complicated all at the same time. As my jumping off point, let\u2019s think of a typical natural cell \u2014 what it is, and what it does. A naturally occurring cell is a little package, essentially its own self-contained unit. It\u2019s got a wrapper around it, and it has a lot of very complicated chemicals inside. That combination of chemicals gives it all sorts of capabilities \u2014 it can eat, it can move, and it can reproduce \u2014 making more of itself.\u00a0<\/p>\n<p>Synthetic cells are similar self-contained units, except they\u2019ve been constructed \u2014 part of them has essentially been built by somebody, and they share one or more features with living cells. They might have genetic material inside them, and the ability to reproduce. They might have a basic metabolism: the ability to turn some chemicals into others, using the enzymes that are inside. Often they are built from a combination of biological and synthetic materials.<\/p>\n<p>Whether they are alive or not depends on particulars. There are some synthetic cells that are so simple that we definitely wouldn\u2019t call them alive \u2014 they don\u2019t have any DNA in them, and they don\u2019t replicate. That\u2019s on one end of the simplicity spectrum. On the other end \u2014 and no one has achieved this yet \u2014 researchers are seeking to build a cell from the ground up with all the necessary components, a functional copy of what otherwise would look like a natural cell. In those cases, the goal is for it to have all the same attributes of a natural cell, and therefore you would consider something like that alive.<\/p>\n<p>In between those two ends of the spectrum, there\u2019s a whole bunch of different possibilities. In our recent report, we use a series of eight case studies to illustrate different points along that spectrum.<\/p>\n<p>Even more recently, the lab of Kate Adamala \u2014 one of our report co-authors \u2014 at the University of Minnesota shared their exciting results for a new synthetic cell that can grow, replicate its own DNA, and divide. It even demonstrates the potential to evolve. The capabilities of this synthetic cell really underscore key conclusions in the report about the need to better understand these new systems.<\/p>\n<p>Q: Why do researchers want to create synthetic cells? What are the potential applications or benefits?<\/p>\n<p>Carr: There are some motivations related to basic research \u2014 seeking to understand the fundamental recipe of life, what the minimum requirements are in order to have a living system. Other researchers have applications in mind in categories that include medicine, agriculture, and environmental monitoring and remediation. For example, one possible application that we discuss in the report is a synthetic cell designed for breaking down environmental contaminants \u2014 chemicals that you might find in a site designated by the EPA as a cleanup site \u2014 that could potentially help restore the site to a more natural balance.<\/p>\n<p>Some versions of synthetic cells could be designed not to replicate so that they are easier to control, so you wouldn\u2019t have as much concern about whether they would compete with the organisms that are already in that environment.<\/p>\n<p>Q: That brings up the issue of risk, which your report also explored. What are some of the risks involved in creating synthetic cells and using them in the world?<\/p>\n<p>Carr: To a very large extent, the potential harms from synthetic cells are very similar to what might one might be concerned about with other kinds of engineered organisms where their DNA has been modified in some way. So, some of those risks are that the cells would compete with natural organisms and disturb a balance in the environment. It\u2019s important to note that presence doesn\u2019t equal harm; just because something is in the environment doesn\u2019t mean it\u2019s causing a problem. But there is the potential for competition and an imbalance.<\/p>\n<p>There are also concerns that people who work in pathogens research could accidentally make something more pathogenic and more dangerous. I\u2019m not aware of people working in synthetic cells who are trying to create synthetic pathogens, but that\u2019s a generalized concern in working with any kind of biotechnology-modified organisms, which would include synthetic cells.<\/p>\n<p>So, there are questions of potential harms to an environment, potential harms to humans, and other potential harms that could be biological \u2014 such as things that could influence agriculture or animal health. Based on the evidence so far, the vast majority of potential risks from synthetic cells do not seem fundamentally different from those that are often considered for biotechnology in general, or for genetically modified organisms in general.<\/p>\n<p>However, there is one particular type of synthetic cell which could be notably different in its risk level. It\u2019s referred to as \u201cmirror life,\u201d and recently <a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/www.science.org\/doi\/10.1126\/science.ads9158\">a group of prominent scientists<\/a> came together to say that mirror life represents a different class of hazard than most genetic engineering does.<\/p>\n<p>Q: Can you say more about that? What is mirror life, and why might it pose unique hazards?<\/p>\n<p>Carr: The idea of mirror life is based on the concept that many of the molecules inside of a cell, including DNA and protein, have what\u2019s called \u201chandedness\u201d to them. There are essentially two versions of many chemicals that could exist, and they\u2019re mirror images of each other \u2014 just like my right hand is a mirror image of my left hand \u2014 but not exactly the same.<\/p>\n<p>Nature chose to go with one version of that handedness for many crucial chemicals, like DNA and proteins. If scientists made a synthetic cell that used the opposite versions for its components \u2014 a cell that had the exact mirror image copies of all of those chemicals that are found in the natural cell \u2014 people have raised concerns about the potential impacts and outcomes. For example, the immune systems of humans and animals have not evolved to be on the lookout for mirror image versions, and so they may not be able to defend against a mirror-life bacterium. And there are concerns that that kind of organism would be able to compete with a leg up in natural environments, and therefore might disrupt natural environments.<\/p>\n<p>Q: How good is our ability to even assess risk, when the science of synthetic cells is so fundamentally new? Can we foresee all of the potential harms, or is our ability to predict them limited in ways that we may not even be aware of?<\/p>\n<p>Carr: That\u2019s a really important question. One crucial area of conclusions and recommendations in our report has to do with the need for further study to try to understand both the \u201cknown unknowns\u201d and potentially get at more of the \u201cunknown unknowns.\u201d A lot of effort has been spent in trying to imagine and predict what the potential risks and consequences and harms could be, and evaluating the probability of those, but because this is still so very new, there\u2019s much that we can\u2019t predict yet.<\/p>\n<p>But there are a large number of possible experiments that one can do with earlier-stage, simpler synthetic cells that could help us evaluate the risk. I\u2019ll give one example. Suppose you have a synthetic cell that does not replicate, but that still uses a little bit of DNA as part of its machinery to get something useful done, like breaking down a dangerous chemical in the environment. That little piece of DNA is unlikely to cause harm by sitting around, but because it\u2019s an unusual, novel synthetic cell, we don\u2019t know how long it\u2019s going to sit around in the environment. So, it\u2019d be nice to first do a controlled lab study, and then possibly a field study, to answer some questions: How long does it persist? Is there evidence that its DNA gets taken up by other organisms, and if it does, is there any observed or speculated problem that that might cause?<\/p>\n<p>And so, we recommend that organizations that fund research work together to support research to understand the potential risks and the probabilities of these different outcomes.<\/p>\n<p>Q: Who should weigh the potential risks and benefits in this research and make decisions \u2014 for example, deciding whether a particular type of research or application should go forward, and how it should go forward? Should it be researchers, regulators, Congress? How should governance work?<\/p>\n<p>Carr: In the report we lay out a vision for how multiple stakeholders \u2014 Congress, agencies, universities, and researchers, among others \u2014 should work together to make those decisions and oversee this research. We call for engagement with the public that is not just one way, but is instead a dialogue, a two-way discussion. We ought to be concerned about the questions people have. Researchers and regulators should be informed about what people care about and how they might be affected, from a variety of perspectives \u2014 community, religious, ethical, and others. So, a complex network of people should be informing decisions about synthetic cells.<\/p>\n<p>Who should make the decisions also depends a bit on which questions are being answered. Regulators and institutional review boards working with researchers should be making a significant number of those decisions. In the U.S., the regulation of biotech and related research is somewhat fragmented between entities like FDA, EPA, and USDA. There\u2019s understandable history for why that\u2019s the case, but what we want is something that is consistent across different agencies. The novelty of synthetic cells merits some adaptation and reinvention of how they are regulated and monitored. One of our recommendations is for an interagency synthetic cell working group \u2014 so that there can be communication and hopefully consistency across how those different relevant agencies would regulate the products of synthetic cell research.<\/p>\n","protected":false},"excerpt":{"rendered":"Peter Carr, co-chair of the Committee on External Review of Environmental, Biosafety, and Biosecurity Considerations for Synthetic Cell&hellip;\n","protected":false},"author":2,"featured_media":514321,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[111,139,69,147],"class_list":["post-514320","post","type-post","status-publish","format-standard","has-post-thumbnail","category-science","tag-new-zealand","tag-newzealand","tag-nz","tag-science"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/514320","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/comments?post=514320"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/514320\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media\/514321"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media?parent=514320"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/categories?post=514320"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/tags?post=514320"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}